Sunshine Lake Pharma Co., Ltd.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Sunshine Lake Pharma Co., Ltd.
RECRUITINGPhase 3NCT05586074
HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML
A randomized，multicenter, open-label Phase III, clinical study is conducted to evaluate the clinical benefit Clifutinib in Chinese patients with relapsed/ refractory (R/R)...
Sponsor: Sunshine Lake Pharma Co., Ltd.Enrolling: 3241 location
Leukemia, Acute Myeloid (AML)
RECRUITINGPhase 1 / Phase 2NCT05451602
HEC169096 in Participants With Advanced Solid Tumors
An Open, Multi-Center Phase I/II Clinical Study To Evaluate The Safety, Tolerability, Pharmacokinetic Characteristics And Effectiveness Of HEC169096 In Patients With Thyroid...
Sponsor: Sunshine Lake Pharma Co., Ltd.Enrolling: 4561 location
Advanced Solid Tumor